About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 620384, 9 pages
http://dx.doi.org/10.1155/2012/620384
Research Article

Inhibitory Activities of Zygophyllum album: A Natural Weight-Lowering Plant on Key Enzymes in High-Fat Diet-Fed Rats

1Laboratory of Animal Ecophysiology, Faculty of Sciences of Sfax, University of Sfax, P.O. Box 95, Sfax 3000, Tunisia
2Laboratory of Chemistry of Natural Products, Faculty of Sciences of Sfax, B.P. 1171, Sfax 3000, Tunisia
3Biotechnology High School of Sfax (ISBS), University of Sfax, P.O. Box 261, Sfax 3052, Tunisia
4Hematological and Clinical Biochemistry Laboratory, Hospital of Sidi Bouzid, Sidi Bouzid 9100, Tunisia

Received 13 May 2012; Accepted 13 August 2012

Academic Editor: David Mischoulon

Copyright © 2012 Kais Mnafgui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Formiguera and A. Cantón, “Obesity: epidemiology and clinical aspects,” Best Practice and Research, vol. 18, no. 6, pp. 1125–1146, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. W. Haslam and W. P. T. James, “Obesity,” The Lancet, vol. 366, no. 9492, pp. 1197–1209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. L. Power and J. Schulkin, “Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins,” British Journal of Nutrition, vol. 99, no. 5, pp. 931–940, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. Grundy, “Obesity, metabolic syndrome, and cardiovascular disease,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2595–2600, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Singla, A. Bardoloi, and A. A. Parkash, “Metabolic effects of obesity,” A Review World Journal of Diabetes, vol. 1, no. 3, pp. 76–88, 2010. View at Publisher · View at Google Scholar
  6. L. A. Profenno, A. P. Porsteinsson, and S. V. Faraone, “Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders,” Biological Psychiatry, vol. 67, no. 6, pp. 505–512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. J. Lavie, R. V. Milani, and H. O. Ventura, “Obesity and cardiovascular disease. risk factor, paradox, and impact of weight loss,” Journal of the American College of Cardiology, vol. 53, no. 21, pp. 1925–1932, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Yusuf, S. Reddy, S. Ôunpuu, and S. Anand, “Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization,” Circulation, vol. 104, no. 22, pp. 2746–2753, 2001. View at Scopus
  9. G. Anfossi, P. Massucco, K. Bonomo, and M. Trovati, “Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 14, no. 4, pp. 215–224, 2004. View at Scopus
  10. B. Rahul, R. B. Birari, and K. K. Bhutani, “Pancreatic lipase inhibitors from natural sources unexplored potential,” Drug Discovery Today, vol. 12, no. 19-20, pp. 879–889, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Tackholm, Students Flora of Egypt, Cairo University Press, Cairo, Egypt, 1977.
  12. B. A. Beier, M. W. Chase, and M. Thulin, “Phylogenetic relationships and taxonomy of subfamily Zygophylloideae (Zygophyllaceae) based on molecular and morphological data,” Plant Systematics and Evolution, vol. 240, no. 1–4, pp. 11–39, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. H. H. Hassanean, E. K. Desoky, and M. M. A. El-Hamouly, “Quinovic acid glycosides from Zygophyllum album,” Phytochemistry, vol. 33, no. 3, pp. 663–666, 1993. View at Scopus
  14. D. Smati, A. Longeon, and M. Guyot, “3β-(3,4-Dihydroxycinnamoyl)-erythrodiol, a cytotoxic constituent of Zygophyllum geslini collected in the Algerian Sahara,” Journal of Ethnopharmacology, vol. 95, no. 2-3, pp. 405–407, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Y. Moustafa, A. I. Khodhair, F. M. Hammouda, and H. A. Husseiny, “Phytochemical and toxicological studies of Zygophyllum album L.F.,” Journal of Pharmacology and Toxicology, vol. 2, no. 3, pp. 220–237, 2007. View at Publisher · View at Google Scholar
  16. S. R. Hussein, M. M. Marzouk, L. F. Ibrahim, S. A. Kawashty, and N. A. M. Saleh, “Flavonoids of Zygophyllum album L.f. and Zygophyllum simplex L., (Zygophyllaceae),” Biochemical Systematics and Ecology, vol. 39, no. 4–6, pp. 778–780, 2011. View at Publisher · View at Google Scholar
  17. J. El Ghoul, N. Ghanem-Boughanmi, and M. Ben-Attia, “Biochemical study on the protective effect of ethanolic extract of Zygophyllum album on streptozotocin-induced oxidative stress and toxicity in mice,” Biomedicine & Preventive Nutrition, vol. 1, no. 2, pp. 79–83, 2011.
  18. H. Y. Chen, Y. C. Lin, and C. L. Hsieh, “Evaluation of antioxidant activity of aqueous extract of some selected nutraceutical herbs,” Food Chemistry, vol. 104, no. 4, pp. 1418–1424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Djeridane, M. Yousfi, B. Nadjemi, D. Boutassouna, P. Stocker, and N. Vidal, “Antioxidant activity of some algerian medicinal plants extracts containing phenolic compounds,” Food Chemistry, vol. 97, no. 4, pp. 654–660, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Nakai, Y. Fukui, S. Asami et al., “Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro,” Journal of Agricultural and Food Chemistry, vol. 53, no. 11, pp. 4593–4598, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. H. G. Shertzer, S. E. Woods, M. Krishan, M. B. Genter, and K. J. Pearson, “Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet,” Journal of Nutrition, vol. 141, no. 4, pp. 582–587, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Medrikova, Z. M. Jilkova, K. Bardova, P. Janovska, M. Rossmeisl, and J. Kopecky, “Sex differences during the course of diet-induced obesity in mice: adipose tissue expandability and glycemic control,” International Journal of Obesity, vol. 36, pp. 262–272, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Moussavi, V. Gavino, and O. Receveur, “Could the quality of dietary fat, and not just its quantity, be related to risk of obesity,” Obesity, vol. 16, no. 1, pp. 7–15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Macotela, J. Boucher, T. T. Tran, and C. R. Kahn, “Sex and depot differences in adipocyte insulin sensitivity and glucose,” Diabetes, vol. 58, no. 4, pp. 803–812, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. H. J. Park, J. Y. Cho, M. K. Kim et al., “Anti-obesity effect of Schisandra chinensis in 3T3-L1 cells and high fat diet-induced obese rats,” Food Chemistry, vol. 134, no. 1, pp. 227–234, 2012. View at Publisher · View at Google Scholar
  26. R. Birari, V. Javia, and K. K. Bhutani, “Antiobesity and lipid lowering effects of Murraya koenigii (L.) Spreng leaves extracts and mahanimbine on high fat diet induced obese rats,” Fitoterapia, vol. 81, no. 8, pp. 1129–1133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Maiza, V. Hammiche, and R. A. Brac de la Perrière, “Traditional saharian pharmacopoeia,” in ISHS Acta Horticulturae, H. Schilcher, J. D. Phillipson, and D. Loew, Eds., p. 332, WOCMAP I–Medicinal and Aromatic Plants Conference, Maastricht, The Netherlands, 1993.
  28. G. J. McDougall and D. Stewart, “The inhibitory effects of berry polyphenols on digestive enzymes,” BioFactors, vol. 23, no. 4, pp. 189–195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Yamamoto, S. Shimura, Y. Itoh, T. Ohsaka, M. Egawa, and S. Inoue, “Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet,” International Journal of Obesity, vol. 24, no. 6, pp. 758–764, 2000. View at Scopus
  30. N. A. M. Saleh and M. N. El-Hadidi, “An approach to the chemosystematics of the zygophyllaceae,” Biochemical Systematics and Ecology, vol. 5, no. 2, pp. 121–128, 1977. View at Scopus
  31. A. F. Hofmann and B. Borgström, “The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption,” The Journal of Clinical Investigation, vol. 43, pp. 247–257, 1964. View at Scopus
  32. A. Halpern and M. C. Mancini, “Treatment of obesity: an update on anti-obesity medications,” Obesity Reviews, vol. 4, no. 1, pp. 25–42, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. G. J. McDougall, N. N. Kulkarni, and D. Stewart, “Berry polyphenols inhibit pancreatic lipase activity in vitro,” Food Chemistry, vol. 115, no. 1, pp. 193–199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Carrière, C. Renou, S. Ransac et al., “Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers,” American Journal of Physiology, vol. 281, no. 1, pp. G16–G28, 2001. View at Scopus
  35. S. Subramaniam, R. Subramaniam, S. Rajapandian, S. Uthrapathi, V. R. Gnanamanickam, and G. P. Dubey, “Anti-atherogenic activity of ethanolic fraction of terminalia arjuna bark on hypercholesterolemic rabbits,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 487916, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Perry, J. Junzeng Zhang, C. Sun, T. Saleh, and Y. Wang, “Liuwei Dihuang lowers bodyweight and improves insulin and leptin sensitivity in obese rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 847167, 8 pages, 2012. View at Publisher · View at Google Scholar
  37. J. L. Wang, N. Chinookoswong, S. Scully, M. Qi, and Z. Q. Shi, “Differential effects of leptin in regulation of tissue glucose utilization in vivo,” Endocrinology, vol. 140, no. 5, pp. 2117–2124, 1999. View at Scopus
  38. F. Galletti, L. D. Elia, D. De Palma et al., “Hyperleptinemia is associated with hypertension, systemic inflammation and insulin resistance in overweight but not in normal weight men,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 22, no. 3, pp. 300–306, 2012. View at Publisher · View at Google Scholar
  39. P. L. Golden, T. J. Maccagnan, and W. M. Pardridge, “Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels,” Journal of Clinical Investigation, vol. 99, no. 1, pp. 14–18, 1997. View at Scopus
  40. R. V. Considine, M. K. Sinha, M. L. Heiman et al., “Serum immunoreactive-leptin concentrations in normal-weight and obese humans,” New England Journal of Medicine, vol. 334, no. 5, pp. 292–295, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. G. H. Lee, R. Proenca, J. M. Montez et al., “Abnormal splicing of the leptin receptor in diabetic mice,” Nature, vol. 379, no. 6566, pp. 632–635, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. E. W. Shek, M. W. Brands, and J. E. Hall, “Chronic leptin infusion increases arterial pressure,” Hypertension, vol. 31, no. 1, pp. 409–414, 1998. View at Scopus
  43. M. Barton, R. Carmona, J. Ortmann, J. E. Krieger, and T. Traupe, “Obesity-associated activation of angiotensin and endothelin in the cardiovascular system,” International Journal of Biochemistry and Cell Biology, vol. 35, no. 6, pp. 826–837, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Masuo, H. Mikami, T. Ogihara, and M. L. Tuck, “Weight reduction and pharmacologic treatment in obese hypertensives,” American Journal of Hypertension, vol. 14, no. 6 I, pp. 530–538, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. E. L. Santos, K. de Picoli Souza, E. D. da Silva et al., “Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats,” Biochemical Pharmacology, vol. 78, no. 8, pp. 951–958, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. F. M. Sacks, W. C. Willett, A. Smith, L. E. Brown, B. Rosner, and T. J. Moore, “Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake,” Hypertension, vol. 31, no. 1 I, pp. 131–138, 1998. View at Scopus
  47. M. R. Joffres, D. M. Reed, and K. Yano, “Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study,” American Journal of Clinical Nutrition, vol. 45, no. 2, pp. 469–475, 1987. View at Scopus